7 completed, 2 unknown, 1 terminated, 1 withdrawn. 11 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Completed 7, Unknown 2, Terminated 1, Withdrawn 1 |
| Phase 2 | 5 | Completed 2, Terminated 1, Unknown 1, Withdrawn 1 |
Follow Short Bowel Syndrome: new trials by email Literature Review of Short Bowel Syndrome trials Research Report on Short Bowel Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of PJ009 in Healthy Adult Volunteers PJ009, Placebo - Short Bowel Syndrome | Phase 1 | Completed | Chongqing Peg-Bio Biopharm Co., Ltd. | 24 | 2023-02-28 | 2024-07-29 |
| Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome Amoxicillin, Levofloxacin, Ofloxacin - Short Bowel Syndrome, Infection, Bacterial | Phase 1 | Unknown | Central Hospital, Nancy, France | 10 | 2022-12-09 | 2024-08-29 |
| Study of NST-6179 in Healthy Subjects NST 6179, Placebo - Short Bowel Syndrome, Parenteral Nutrition Associated Liver Disease | Phase 1 | Completed | NorthSea Therapeutics B.V. | 70 | 2021-11-11 | 2024-06-24 |
| Proof of Concept Study in Patients With Short Bowel Syndrome NM-002 - Short Bowel Syndrome | Phase 1 / Phase 2 | Unknown | 9 Meters Biopharma, Inc. | 12 | 2020-06-23 | 2020-11-20 |
| Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support FE203799 GLP-2 analogue, FE203799 Placebo GLP-2 analogue - Short Bowel Syndrome | Phase 1 / Phase 2 | Completed | GlyPharma Therapeutics | 8 | 2018-05-08 | 2024-10-26 |
| Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency FE203799 - SBS - Short Bowel Syndrome | Phase 1 / Phase 2 | Completed | GlyPharma Therapeutics | 8 | 2018-05-02 | 2024-10-24 |
| Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome | Phase 1 / Phase 2 | Terminated | Alberta Children's Hospital | 13 | 2012-01-01 | 2014-12-23 |
| Investigational Study of Oral Fish Oil in Treating Parenteral Nutrition Associated Liver Disease Lovaza (omega-3-acid ethyl ester), Corn oil - Liver Disease, Short Bowel Syndrome | Phase 1 / Phase 2 | Withdrawn | Boston Children's Hospital | 2011-01-01 | 2017-06-22 | |
| Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers Teduglutide - Healthy | Phase 1 | Completed | Nycomed | 72 | 2009-11-01 | 2012-05-07 |
| Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome Oral, live, pentavalent rotavirus vaccine; RotaTeq(R) - Short Bowel Syndrome | Phase 1 | Completed | Children's Hospital of Michigan | 8 | 2009-07-01 | 2014-06-13 |
| Cholestasis Prevention: Efficacy of IV Fish Oil Omegaven, Intralipid - Cholestasis, Parenteral Nutrition | Phase 1 | Completed | Boston Children's Hospital | 19 | 2007-07-01 | 2020-12-03 |
Bacterial Infections (1) · Cholestasis (1) · Enterocolitis, Necrotizing (1) · Gastroschisis (1) · Hyperphagia (1) · Infant Nutrition Disorders (1) · Intestinal Atresia (1) · Intestinal Failure (1) · Liver Diseases (1) · Malnutrition (1)
Digestive System Diseases (11) · Gastrointestinal Diseases (11) · Intestinal Diseases (11) · Malabsorption Syndromes (11) · Pathologic Processes (11) · Pathological Conditions, Signs and Symptoms (11) · Postoperative Complications (11) · Bacterial Infections and Mycoses (1) · Bile Duct Diseases (1) · Biliary Tract Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Digestive System Abnormalities (1) · Enterocolitis (1) · Gastroenteritis (1)
Amoxicillin (1) · Corn Oil (1) · Fish Oils (1) · Glucagon-Like Peptide 2 (1) · Levofloxacin (1) · Ofloxacin (1) · Omacor (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1) · fish oil triglycerides (1) · soybean oil, phospholipid emulsion (1) · teduglutide (1)
Boston Children's Hospital (2) · GlyPharma Therapeutics (2) · 9 Meters Biopharma, Inc. (1) · Alberta Children's Hospital (1) · Central Hospital, Nancy, France (1) · Children's Hospital of Michigan (1) · Chongqing Peg-Bio Biopharm Co., Ltd. (1) · NorthSea Therapeutics B.V. (1) · Nycomed (1)
United States (4) · Denmark (2) · Canada (1) · China (1) · France (1) · Germany (1) · United Kingdom (1)
Tomasz Masior (2) · David Sigalet, MD PhD (1) · Eric J McGrath, MD (1) · Mark Puder, MD, PhD (1) · Ruigang Hou (1) · Tom Jaksic, MD, PhD (1)
PMID 15530127, PMID 1559306, PMID 20094812, PMID 2292168, PMID 23770843, PMID 24667978, PMID 29127863, PMID 34287970, PMID 6699766, PMID 7619677, PMID 7924123, PMID 9724482